USPTO serial 79349337
BIONTECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 8, 2023
- Examiner
- RENNEKER, CHRISTOPHER JOHN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIONTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, NW10th FloorWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; adjuvants for use in manufacture of vaccines; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes | ACTIVE | — |
| 005 | Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines; chemical reagents used for medical purposes; biochemical reagents used for purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; diagnostic preparations for clinical or medical laboratory use | ACTIVE | — |
| 009 | Downloadable mobile applications for enabling healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; downloadable computer software for enabling healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; downloadable e-commerce computer software for enabling users to perform electronic business transactions via a global computer network | ACTIVE | — |
| 010 | Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancer, infectious diseases, and immunological diseases; medical diagnostic devices for analysis of body fluids and biopsies for patient stratification | ACTIVE | — |
| 035 | Business advisory services in the field of electronic commerce; providing business information in the field of electronic commerce; providing business information, namely, customer information on pharmaceutical and medical products through an on-line computer network; wholesale and retail store services featuring pharmaceutical products, medicinal preparations, and medical supplies | ACTIVE | — |
| 042 | Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; medical and scientific research services by compiling data for clinical trials and drug admission | ACTIVE | — |
| 044 | Medical, hygienic and beauty care; health care; providing medical information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical products, medical diseases and disorders and related treatments via the Internet; gene and cell therapy; medical and psychological counselling services; medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioNTech SE
- Other trademarks owned by BioNTech SE
- Other trademarks owned by BioNTech SE
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIONTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 31, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 13, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 13, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 8, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 25, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 25, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 8, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 8, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 31, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 3, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 3, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 18, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 18, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 31, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Dec 28, 2022 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 17, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 20, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 15, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |